Corpus Intelligence IC Memo — MEMORIAL EASTON 2026-04-26 09:36 UTC
IC Memo — MEMORIAL EASTON
Investment Committee Memorandum | MD | 143 beds | Grade C | EBITDA uplift $21.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MEMORIAL EASTON

CCN 210037 | TALBOT, MD | 143 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MEMORIAL EASTON is a 143-bed suburban community hospital in TALBOT, MD with $287.6M in net patient revenue and a -4.1% operating margin. The hospital serves a payer mix of 55.9% Medicare, 6.0% Medicaid, and 38.1% commercial.

Thesis: Undervalued. Our ML models identify $21.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.1% to 3.2% (+736bps).

Net Revenue HCRIS$287.6M
Current EBITDA COMPUTED$-11.9M
Operating Margin COMPUTED-4.1%
Occupancy HCRIS63.0%
Revenue / Bed COMPUTED$2.0M
Net-to-Gross HCRIS77.1%
Distress Probability ML51.0%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
35
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -4.1% places it above the state median. Among 35 size-comparable peers (72-286 beds), the median margin is -7.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (72-286), prioritizing same-state peers. 35 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MEMORIAL EASTON (Target)MD143$287.6M-4.1%
MERCY MEDICAL CENTERMD173$561.3M-3.3%
ST. AGNES HOSPITALMD183$506.7M-12.2%
TIDALHEALTH PENINSULA REGIONALMD230$493.4M0.8%
GREATER BALTIMORE MEDICAL CENTMD265$420.3M-48.5%
MEDSTAR UNION MEMORIAL HOSPITAMD191$409.3M-8.7%
ST. JOSEPH MEDICAL CENTERMD225$398.0M-3.2%
MERITUS MEDICAL CENTERMD265$396.2M1.5%
FREDERICK MEMORIAL HOSPITALMD279$388.7M-6.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $21.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$6.0M+210bp18mo
Cost to Collect4.5%2.5%$5.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.5M+122bp9mo
Clean Claim Rate88.0%96.0%$184K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$6.0M
Cost to Collect
$5.8M
Denial Rate Reduction
$5.7M
A/R Days Reduction
$3.5M
Clean Claim Rate
$184K
Total EBITDA Uplift$21.2M
Current EBITDA$-11.9M
+ RCM Uplift+$21.2M
Pro Forma EBITDA$9.3M
Current Margin-4.1%
Pro Forma Margin3.2%
WC Released (1x)$11.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-18.2M$133.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-18.2M$140.9M0.00x-100.0%
Bull Case9.0x11.0x$-16.4M$204.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-16.4M$218.6M0.00x-100.0%
Bear Case11.0x10.0x$-20.1M$33.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-20.1M$30.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 55.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
HighElevated distress probabilityModel estimates 51.0% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 35 hospitals with 72-286 beds
  • Same-state prioritization (n=36)
  • Comp margins: P25=-12.5% / P50=-7.6% / P75=-1.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.